New 2,3-benzodiazepine derivative: Synthesis, activity on central nervous system, and toxicity study in mice

5Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

We report the design and synthesis of a new diazepine derivative, 4-(4-methoxyphenyl)-2,3,4,5-tetrahydro-2,3-benzodiazepin-1-one (VBZ102), and the evaluation of its anxiolytic-like profile, memory impairment effect, and toxicity in Swiss mice. VBZ102 was evaluated for central nervous system effects in an open field, light–dark box, and novel object recognition tests under oral administration for acute and sub-acute treatment. We tested the VBZ102 toxicity in mice through a determination of LD50 values and examination of the biochemical and histopathological parameters. The VBZ102 induced an anxiolytic effect at different doses both in the light–dark box and open field tests. Unlike other benzodiazepines (e.g., bromazepam), a sedative effect was noted only after administration of the VBZ102 at 10.0 mg/kg.

Cite

CITATION STYLE

APA

Amaghnouje, A., Bohza, S., Bohdan, N., Es-Safi, I., Kyrylchuk, A., Achour, S., … Grafov, A. (2021). New 2,3-benzodiazepine derivative: Synthesis, activity on central nervous system, and toxicity study in mice. Pharmaceuticals, 14(8). https://doi.org/10.3390/ph14080814

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free